longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

AstraZeneca (AZN) was upgraded to a Hold Rating at Deutsche Bank

Tip Ranks
Sep 15, 2026 at 07:35 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi. According to TipRanks, Papadakis has an average return of 4.1% and a 52.45% success rate on recommended stocks. In addition to Deutsche Bank , AstraZeneca also received a Hold from HSBC’s Rajesh Kumar in a report issued on September 10. However, yesterday, Berenberg Bank maintained a Buy rating on AstraZeneca (LSE: AZN).

AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today.

Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi. According to TipRanks, Papadakis has an average return of 4.1% and a 52.45% success rate on recommended stocks.

In addition to Deutsche Bank , AstraZeneca also received a Hold from HSBC’s Rajesh Kumar in a report issued on September 10. However, yesterday, Berenberg Bank maintained a Buy rating on AstraZeneca (LSE: AZN).

Login to unlock49characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Mar 19, 2026 at 02:07 AMThe employment impact of AI is becoming increasingly significant! HSBC is considering large-scale layoffs
  • Mar 18, 2026 at 04:19 PMHSBC: The stock market is pricing in a "recession" rather than "stagflation," and there are oversold opportunities in em…
  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
  • Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
  • Feb 6, 2026 at 11:05 AMHSBC firmly "reduces holdings" in Korean stocks: a highly consensus trade with significant risks

Related Stocks

AstraZeneca

AstraZeneca

USAZN

+0.64%

AstraZeneca PLC

AstraZeneca PLC

UKAZN

HSBC

HSBC

USHSBC

-1.35%

LongbridgeAI